Key features of the patient-tailored N-acetylcysteine protocol.
Tsai
Chu-Lin
CL
Fang
Cheng-Chung
CC
Walson
Philip D
PD
D000082:Acetaminophen / Q000506:poisoning*; D000111:Acetylcysteine / Q000008:administration & dosage / Q000627:therapeutic use*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D018712:Analgesics, Non-Narcotic / Q000506:poisoning*; D002140:California; D056486:Chemical and Drug Induced Liver Injury / Q000401:mortality / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D062787:Drug Overdose / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D018712:Analgesics, Non-Narcotic; D000082:Acetaminophen; D000111:Acetylcysteine